Search   
MSDS  : 5-beta-Cholan-24-oic acid, 3-alpha,12-alpha-dihydroxy-, sodium salt
CAS  : 302-95-4
SYNONYMS  : * Cholan-24-oic acid, 3,12-dihydroxy-, monosodium salt, (3-alpha,5-beta,12-alpha)- * Deoxycholate sodium * Deoxycholic acid sodium salt * Desoxycholate sodium * Dihydroxy 3-12 cholanate de Na * 3,12-Dihydroxy-cholan-24-oic acid monosodium salt, (3-alpha,5-beta,12-alpha)- * 3-alpha,12-alpha-Dihydroxy-5-beta-cholan-24-oic acid sodium salt * Natrium-3-alpha,12-alpha-dihydroxycholanat * Na-Desoxycholat * Sodium deoxycholate * Sodium 7-deoxycholate * Sodium deoxycholic acid * Sodium desoxycholate
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : FZ2250000
CHEMICAL NAME : 5-beta-Cholan-24-oic acid,
3-alpha,12-alpha-dihydroxy-, sodium salt
CAS REGISTRY NUMBER : 302-95-4
LAST UPDATED : 199701
DATA ITEMS CITED : 20
MOLECULAR FORMULA : C24-H39-O4.Na
MOLECULAR WEIGHT : 414.62
WISWESSER LINE NOTATION : L E5 B666TJ A1 DQ E1 FY1&2VO OQ &-NA-
COMPOUND DESCRIPTOR : Drug
Mutagen
Reproductive Effector
SYNONYMS/TRADE NAMES :
* Cholan-24-oic acid, 3,12-dihydroxy-, monosodium salt,
(3-alpha,5-beta,12-alpha)-
* Deoxycholate sodium
* Deoxycholic acid sodium salt
* Desoxycholate sodium
* Dihydroxy 3-12 cholanate de Na
* 3,12-Dihydroxy-cholan-24-oic acid monosodium salt,
(3-alpha,5-beta,12-alpha)-
* 3-alpha,12-alpha-Dihydroxy-5-beta-cholan-24-oic acid sodium salt
* Natrium-3-alpha,12-alpha-dihydroxycholanat
* Na-Desoxycholat
* Sodium deoxycholate
* Sodium 7-deoxycholate
* Sodium deoxycholic acid
* Sodium desoxycholate

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1370 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex)
Behavioral - ataxia
Lungs, Thorax, or Respiration - other changes
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,45,1969

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 123 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex)
Behavioral - ataxia
Lungs, Thorax, or Respiration - other changes
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,45,1969

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 2430 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex)
Behavioral - ataxia
Lungs, Thorax, or Respiration - other changes
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,45,1969

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 150 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 20,323,1970

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1050 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Gastrointestinal - ulceration or bleeding from stomach
Gastrointestinal - ulceration or bleeding from small intestine
REFERENCE :
ESKHA5 Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic
Sciences. (Kokuritsu Eisei Shikenjo Kagaku, 18-1 Bushitsu Johobu,
Setagaya-ku, Tokyo 158, Japan) V.1- 1886- Volume(issue)/page/year:
(103),29,1985

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 36 mg/kg
TOXIC EFFECTS :
Behavioral - excitement
Lungs, Thorax, or Respiration - other changes
Gastrointestinal - hypermotility, diarrhea
REFERENCE :
ESKHA5 Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic
Sciences. (Kokuritsu Eisei Shikenjo Kagaku, 18-1 Bushitsu Johobu,
Setagaya-ku, Tokyo 158, Japan) V.1- 1886- Volume(issue)/page/year:
(103),29,1985

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 815 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex)
Behavioral - ataxia
Lungs, Thorax, or Respiration - other changes
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,45,1969

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 107 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans
Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4-
1898- Volume(issue)/page/year: 90,18,1952

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 15 mg/kg
TOXIC EFFECTS :
Cardiac - other changes
Lungs, Thorax, or Respiration - acute pulmonary edema
Blood - other changes
REFERENCE :
ZGEMAZ Zeitschrift fuer die Gesamte Experimentelle Medizin. (Berlin, Fed.
Rep. Ger.) V.1-139, 1913-65. For publisher information, see REXMAS.
Volume(issue)/page/year: 52,779,1926

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 700 mg/kg/28D-C
TOXIC EFFECTS :
Gastrointestinal - other changes
Liver - changes in liver weight
Lungs, Thorax, or Respiration - changes in lung weight
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,45,1969

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 6 gm/kg/30D-I
TOXIC EFFECTS :
Liver - changes in liver weight
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - transaminases
Related to Chronic Data - death
REFERENCE :
ESKHA5 Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic
Sciences. (Kokuritsu Eisei Shikenjo Kagaku, 18-1 Bushitsu Johobu,
Setagaya-ku, Tokyo 158, Japan) V.1- 1886- Volume(issue)/page/year:
103,29,1985

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE : 1400 mg/kg
SEX/DURATION : male 28 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - prostate, seminal vesicle, Cowper's gland,
accessory glands
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,45,1969

** MUTATION DATA **

TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Bacteria - Escherichia coli
DOSE/DURATION : 5 pph/3H
REFERENCE :
CSHSAZ Cold Spring Harbor Symposia on Quantitative Biology. (Cold Spring
Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1933-
Volume(issue)/page/year: 12,256,1947

TYPE OF TEST : Sex chromosome loss and nondisjunction
TEST SYSTEM : Mold - Aspergillus nidulans
DOSE/DURATION : 960 mg/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 93,101,1982

TYPE OF TEST : Unscheduled DNA synthesis
TEST SYSTEM : Human Fibroblast
DOSE/DURATION : 25 mg/L
REFERENCE :
NUCADQ Nutrition and Cancer. (Franklin Institute Press, POB 2266,
Phildelphia, PA 19103) V.1- 1978- Volume(issue)/page/year: 16,227,1991

TYPE OF TEST : DNA inhibition
TEST SYSTEM : Human Lymphocyte
DOSE/DURATION : 100 mg/L
REFERENCE :
BECTA6 Bulletin of Environmental Contamination and Toxicology.
(Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ
07094) V.1- 1966- Volume(issue)/page/year: 28,504,1982

TYPE OF TEST : Unscheduled DNA synthesis
ROUTE OF EXPOSURE : Rectal
TEST SYSTEM : Rodent - rat
DOSE/DURATION : 10 umol/kg
REFERENCE :
GANNA2 Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75,
1907-84. For publisher information, see JJCREP. Volume(issue)/page/year:
75,29,1984

*** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***

NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
NOHS - National Occupational Hazard Survey (1974)
NOHS Hazard Code - 83389
No. of Facilities: 138 (estimated)
No. of Industries: 1
No. of Occupations: 2
No. of Employees: 361 (estimated)

NOES - National Occupational Exposure Survey (1983)
NOES Hazard Code - 83389
No. of Facilities: 673 (estimated)
No. of Industries: 6
No. of Occupations: 9
No. of Employees: 7419 (estimated)
No. of Female Employees: 5995 (estimated)

*** STATUS IN U.S. ***

EPA TSCA Section 8(b) CHEMICAL INVENTORY


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
Chloric acid, sodium salt, mixt. with urea 102340-92-1
Chloric acid, thallium(1+) salt 13453-30-0
Chloriertes camphenSUBSTANCE DEFINITION :Consists of a mixture of chlorinated camphene with 67-69% chlorineREFERENCE :85GYAV "Pflanzenschutz-und Schaedlingsbekaempfungsmittel: Abriss einerToxikologie und Therapie von Vergiftungen," 2nd ed., Klimmer, O.R.,Hattingen, Fed. Rep. Ger., Hundt-Verlag, 1971 Volume(issue)/page/year:-,50,1971 13453-30-0
Chlorinated poly(vinyl chloride), pyrolyzate 13453-30-0
5-beta-Card-20(22)-enolide,3-beta-((2,6-dideoxy-3,4-O-(1-phenylmethyl)propylidene)-beta-D- ribo-hexopyranosyl)-5,14-dihydroxy-19-oxo- 35811-18-8
Chlorinated trisodium phosphate 11084-85-8
Chlorine 7782-50-5
Chlorine fluoride 7790-91-2
Chlorine fluoride (ClF5) 13637-63-3
Chlorine oxide 10049-04-4
Chlorisofos 76774-73-7
Chlorite 14998-27-7
Chlorocarcin A, dihydrochloride, hydrate 14998-27-7
Chlorocarcin B 59493-95-7
Chloroform 67-66-3
Card-20(22)-enolide,3-((2,6-dideoxy-4-O-beta-D-xylopyranosyl-beta-D-ribo-hexopyranosyl)oxy)- 5,14-dihydroxy-19-oxo-,(3-beta,5-beta)- 630-65-9
Chloroparaffin XP-470 630-65-9
Chlorophyll 1406-65-1
Chloroprene rubber 1406-65-1
Chlorostatin 37246-59-6
Chlorosulfuric acid 7790-94-5
Chlorosulfuric acid, (2-chloroethyl) ester 13891-58-2
Chlorosulfuric acid, (2-fluoroethyl) ester 371-94-8
Chlorothricin, 2(A)-hydroxy-, (2(A)R)-, (9CI) 111810-18-5
Chlorous acid, silver(1+) salt 7783-91-7
Chocolate Brown FB 12236-46-3
Card-20(22)-enolide,3-((diethylaminoacetyl)oxy)-5,14-dihydroxy-19-oxo-,(3-beta,5-beta)- 63979-66-8
Choerospondias axillaris (roxb.) Burtt. et Hill,fruit extract 63979-66-8
Choji (Japanese)SUBSTANCE DEFINITION :Crude drug extract from Syzygium aromaticaREFERENCE :MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AEAmsterdam, Netherlands) V.1- 1964- 63979-66-8
Cholan-24-oic acid, 3,7-bis(sulfooxy)-, trisodiumsalt, (3-alpha,5-beta,7-beta)- 89232-83-7
5-beta-Cholan-24-oic acid, 3-alpha,7-alpha-dihydroxy- 474-25-9
5-beta-Cholan-24-oic acid, 3-alpha,7-beta-dihydroxy- 128-13-2
5-beta-Cholan-24-oic acid, 3-alpha,6-alpha-dihydroxy- 83-49-8
5-beta-Cholan-24-oic acid,3-alpha,12-alpha-dihydroxy- 83-44-3
5-beta-Cholan-24-oic acid,3-alpha,12-alpha-dihydroxy- compd. with acenaphthene 83-44-3
5-beta-Cholan-24-oic acid,3-alpha,12-alpha-dihydroxy-, compd. withcholanthrene, 3-methyl- 83-44-3
5-beta-Cholan-24-oic acid,3-alpha-12-alpha-dihydroxy-, compound withdibenz(a,h)anthracene 83-44-3
5-alpha-Card-20(22)-enolide, 3-alpha,14-dihydroxy- 466-08-0
5-beta-Cholan-24-oic acid,3-alpha,7-alpha-dihydroxy-, monosodium salt 2646-38-0
Cholan-24-oic acid, 3,7-dihydroxy-12-oxo-, sodiumsalt 2646-38-0
Cholan-24-oic acid, 3,12-dihydroxy-7-oxo-, sodiumsalt 2646-38-0
Cholan-24-oic acid, 7,12-dihydroxy-3-oxo-, sodiumsalt 2646-38-0
5-beta-Cholan-24-oic acid,3-alpha,6-alpha-dihydroxy-, sodium salt 31687-62-4
5-beta-Cholan-24-oic acid,3-alpha,12-alpha-dihydroxy-, sodium salt 302-95-4
5-beta-Cholan-24-oic acid, 3,12-dioxo- 2958-05-6
Cholan-24-oic acid, 3,7-dioxo-12-hydroxy-, sodiumsalt 2958-05-6
Cholan-24-oic acid, 3,12-dioxo-7-hydroxy-, sodiumsalt 2958-05-6
Cholan-24-oic acid, 7,12-dioxo-3-hydroxy-, sodiumsalt 2958-05-6
5-beta-Card-20(22)-enolide, 3-alpha,14-dihydroxy- 545-52-8
5-beta-Cholan-24-oic acid, 3,6-dioxo-, sodium salt 545-52-8

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net